Virginia Borges, M.D., MMSc (IMAGE)

University of Colorado Anschutz Medical Campus

Virginia Borges, M.D., MMSc

Caption

Virginia Borges, M.D., MMSc, and colleagues report promising phase 1b results for tucatinib and T-DM1 against HER2+ breast cancer.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.